Get access to our best features
Get access to our best features
Published 3 months ago

Hidradenitis Suppurativa: Positive Results Reported With Anti-IL17A/F Therapies

Summary by
One of the trials evaluated a nanobody inhibitor, sonelokimab, a molecule with a substantially smaller size than traditional monoclonal antibodies.
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

To view factuality data please Upgrade to Premium


To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics